Equiteq advises Livingbridge on its investment in clinical consulting business, Four Eyes Insight.

September 2016

Equiteq, the consulting sector M&A specialist, is pleased to announce its client Livingbridge, an independent private equity investor, has invested in the clinical consulting business, Four Eyes Insight.  Equiteq provided commercial advice and detailed operational development guidance to help validate the investment case and provide a roadmap for rapid scaling and equity growth. The transaction closed on August 17, 2016.

Four Eyes Insight was founded in 2013 by Dr Henry Carleton and Brian Wells. Leveraging the founders’ clinical experience, the business helps acute NHS trusts across the country identify and implement efficiency and performance improvements projects.  Four Eyes Insight have been able to demonstrate lasting productivity improvements which are highly valued by trust management and the regulator, NHSI.   Pete Clarke, partner at Livingbridge’s commented on Equiteq.

“Equiteq were invaluable in providing the roadmap for scaling which enabled us to invest with a clear view on the necessary infrastructure investment and its sequencing.  Their work provided us with the confidence to invest and commit to a transformational business plan which will double the number of employees in the medium term”

Dr Henry Carleton, co-founder and CEO at Four Eyes Insight commented: “We have worked hard to establish ourselves as a key partner for the Trusts we work with, turning medical productivity plans into an operational reality and helping them to achieve significant efficiency gains and savings.  Equiteq’s support and Livingbridge’s investment unleashes a new phase of growth and we are actively recruiting across all areas of the firm to scale rapidly and build on the strong momentum we have generated to date.”

David Cheesman, Group Director, based in Equiteq’s London office, commented, “We were delighted to support Livingbridge and Four Eyes develop an operational plan for robust scaling and equity growth. There is enormous potential in secondary care for Four Eye’s to improve the patient experience and increase value for money with is market leading offerings and Livingbridge’s investment will allow Four Eyes to pursue a significant market opportunity. Equiteq’s expertise in operations and business scaling alongside its investment banking services is a powerful combination that is well aligned to ambitious management team plans and private equity investments”.

To see all of our deals, please click here.

©Equiteq 2016

2017 Global Consulting M&A Report

Our latest report analyses M&A deals from 2016 and provides our insights for 2017

Download now

Equiteq wins Cross Border Deal of the Year ($50 - $100mm) at the M&A Advisor Awards 2016

Read more